CCL14a/HCC-1 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # AF-324-PBA
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Thr20-Asn93
Accession # Q16627
Specificity
Clonality
Host
Isotype
Applications for CCL14a/HCC-1 Antibody [Allophycocyanin]
Western Blot
Neutralization
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: CCL14a/HCC-1
CCL14, is a member of the chemokine superfamily of ligands. In-depth genome analysis has determined that there is no mouse ortholog for human CCL14. Two alternatively spliced isoforms of CCL14, CCL14a/HCC-1 and CCL14b/HHC-3, have been identified. The CCL14a/HCC-1 isoform is a 93 amino acid (aa) precursor peptide with a predicted molecular weight of 10 kDa, while the CCL14b/HCC-3 isoform contains an additional 17 aa insertion and has a predicted molecular weight of 12 kDa. CCL14a/HCC-1 is cleaved into a 74 aa secreted bioactive peptide by Plasmin or u-Plasminogen Activator/Urokinase. CCL14a/HCC-1 binds and activates CCR1, CCR3, and CCR5; it also binds the non-signaling chemokine decoy receptors DARC and D6. CCL14a/HCC-1 is widely expressed in normal tissues including spleen, liver, skeletal and heart muscle, gut, and bone marrow, and it circulates at high concentrations in the plasma. CCL14a/HCC-1 induces the chemotaxis of T lymphocytes, monocytes, and eosinophils. It also exhibits anti-HIV activities by causing CCR5, a key mediator of HIV entry, internalization and intracellular sequestration.
Alternate Names
Gene Symbol
Additional CCL14a/HCC-1 Products
Product Documents for CCL14a/HCC-1 Antibody [Allophycocyanin]
Product Specific Notices for CCL14a/HCC-1 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.